Insights

Targeted funding Small to mid-sized research services organization with 11-50 employees and annual revenue in the 1-10M range presents an opportunity to offer scalable, cost-effective data analytics, cloud-enabled collaboration tools, and modern research IT solutions that align with their ELK stack, Redshift, Azure DevOps, and SPSS usage.

Cancer research focus Strategic emphasis on integrating patient, model system, and single-cell data for mechanistic cancer dynamics suggests potential for partnerships around data integration platforms, imaging analytics, high-content screening support, and translational data pipelines to accelerate discovery.

Tech stack fit Existing tools include iCIMS, SharePoint, Elastic stack, Redshift, Azure DevOps, IBM SPSS, and Cisco; sales opportunities exist in upgrading analytics capabilities, data governance, security hardening, cloud cost optimization, and integration services to streamline workflows.

USC ecosystem Affiliation with USC and the Michelson Center signals proximity to a broad university network and potential for multi-institution collaborations, grants support, and access to clinical data partnerships, enhancing opportunities for research support contracts.

Growth signals Recent USC leadership appointments and campus investments indicate a dynamic university environment; align offerings with institutional initiatives, communications enablement, and academic operations optimization to capture broader engagement across departments.

Similar companies to CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer

CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer Tech Stack

CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer uses 8 technology products and services including iCIMS, Microsoft SharePoint, Elastic stack (ELK), and more. Explore CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's tech stack below.

Media & News

CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's Email Address Formats

CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer uses at least 4 email formats:
CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer Email FormatsExamplePercentage
First.Last@usc.eduJohn.Doe@usc.edu
60%
FLast@usc.eduJDoe@usc.edu
28%
Last@usc.eduDoe@usc.edu
7%
FirstL@usc.eduJohnD@usc.edu
5%

Frequently Asked Questions

What is CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's official website and social media links?

Minus sign iconPlus sign icon
CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's official website is usc.edu and has social profiles on LinkedIn.

How much revenue does CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer generate?

Minus sign iconPlus sign icon
As of September 2026, CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's annual revenue is estimated to be $1M - $10M.

What is CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's NAICS code?

Minus sign iconPlus sign icon
CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's NAICS code is 5417 - Scientific Research and Development Services.

How many employees does CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer have currently?

Minus sign iconPlus sign icon
As of September 2026, CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer has approximately 28 employees across 2 continents, including North America and Europe. Key team members include Director: D. T., Project Manager / Gis Junior Analyst: I. H. and Research Assistant: C. M. Explore CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's employee directory with LeadIQ.

What industry does CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer belong to?

Minus sign iconPlus sign icon
CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer operates in the Research Services industry.

What technology does CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer use?

Minus sign iconPlus sign icon
CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's tech stack includes iCIMS, Microsoft SharePoint, Elastic stack (ELK), Amazon Redshift, Azure DevOps, IBM SPSS, Agentforce and Cisco.

What is CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's email format?

Minus sign iconPlus sign icon
CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's email format typically follows the pattern of First.Last@usc.edu. Find more CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer email formats with LeadIQ.
CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer logo

CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer

Research ServicesCalifornia, United States11-50 Employees

CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer is a research entity based in Los Angeles, California, focused on integrating patient data, model systems, and high-content single-cell information to translate observed clinical correlations into a mechanistic understanding of cancer dynamics. Its work centers on examining the spatial distributions and temporal evolution of cancer across cellular, human, and population scales, with an emphasis on the physical dynamics underlying the disease. The organization operates within the research services space, collaborating to clarify how cancer progresses by linking diverse data types to fundamental biological and physical processes.

Section iconCompany Overview

Website
usc.edu
NAICS Code
5417 - Scientific Research and Development Services
Employees
11-50

Section iconFunding & Financials

  • $1M - $10M

    CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.